There were two possibilities: (1) CRP is the key factor in peripheral inflammation exposing to endothelia and directly involved in ApoE4‐related AD pathogenesis; (2) CRP is a biomarker for peripheral chronic low‐grade inflammation, and other proinflammatory factors impact on ApoE4 to increase AD risk. This evidence concerns the gene APOE and Alzheimer disease.